Acer Therapeutics Inc. (12)

Browse by Contract Category

Contracts

Exclusive License Agreement, dated as of December 21, 2018, by and between Acer Therapeutics Inc. and Sanofi (Filed With SEC on August 13, 2020)
Securities Purchase Agreement, dated July 24, 2020, by and between Acer Therapeutics Inc. and the investors listed on Schedule I thereto (Filed With SEC on July 27, 2020)
Research Collaboration Agreement, dated March 26, 2020, by and between Acer Therapeutics Inc. and the National Center for Advancing Translational Sciences (Filed With SEC on June 1, 2020)
Purchase Agreement, dated as of April 30, 2020 by and between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2020)
Employment agreement, dated September 18, 2019, by and between Acer Therapeutics Inc. and John Klopp (Filed With SEC on November 13, 2019)
Lease Agreement, dated March 5, 2019, by and between Acer Therapeutics Inc. and Commonwealth Development LLC, as a trustee of the Gateway Realty Trust (Filed With SEC on August 13, 2019)
Registration Rights Agreement, dated as of April 30, 2020 by and between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2020)
Amended and Restated Sales Agreement, dated March 18, 2020 by and among Acer Therapeutics Inc., Roth Capital Partners, LLC, and JonesTrading Institutional Services LLC (Filed With SEC on March 18, 2020)
Description of the Companys capital stock registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 18, 2020)
Employment agreement, dated September 18, 2019, by and between Acer Therapeutics Inc. and Matthew T. Seibt (Filed With SEC on November 13, 2019)
Form of Notice of Restricted Stock Award for awards under the 2018 Stock Incentive Plan (Filed With SEC on March 7, 2019)
Employment Agreement, dated December 4, 2018, by and between Acer Therapeutics Inc. and Salma Jutt-Eghbali (Filed With SEC on March 7, 2019)